The GIFT Nifty futures, which is an early indicator of the Nifty50 index, was trading 0.18% higher by 43 points at 23,807, indicating that the domestic benchmark indices are likely to make a positive start on Monday.

On Thursday, 17 April, Domestic benchmark indices S&P BSE Sensex skyrocketed by 1,508 points or 1.96% and settled at 78,553.2 while the Nifty50 traded 1.77% higher by 414 points, settling at 23,852.

Here are some stocks that are likely to remain in focus on 21 April.

Quarterly Results Today: Tata Investment Corporation, Himadri Speciality Chemical, Anant Raj, Pitti Engineering, Mahindra Logistics, International Gemological Institute India, Alok Industries, Rajratan Global Wire, Lotus Chocolate Company, Shilchar Technologies, Aditya Birla Money, Indag Rubber, Siel Financial Services, and Shekhawati Industries are some of the prominent companies set to announce their quarterly earnings for January-March. 

Coal India: The subsidiary of the company, SECL, has announced that it will enter into a Rs 7,040 crore agreement with TMC Mineral Resources to undertake large-scale coal production using paste-filling technology.

Divis Laboratories: The company has announced signing a confidential long-term agreement with a global pharmaceutical company for manufacturing and supplying advanced intermediates with an investment plan of Rs 650-700 crore in capacity expansion. 

Zydus Lifesciences: Zydus MedTech, a subsidiary of the company, has announced entering into a strategic partnership with Braile Biomedica (a cardiovascular device manufacturer in Brazil) to exclusively commercialize its Transcatheter Aortic Valve Implantation technology across India, Europe, and other selected markets. 

HDFC Bank: In its quarterly earnings for January-March, the company reported a 6.7% year-on-year increase in its net profit to Rs 17,616 crore for the quarter under review. Moreover, the net interest income of the company grew by 10% YoY to Rs 32,065.8 crore. 

Cipla: The company’s subsidiary’s Medispray facility in Goa has been classified as ‘voluntary action indicated’ by the US Food and Drug Administration (USFDA). 

Aster DM Healthcare: The company has announced securing approval from the Competition Commission of India for its merger with Quality Care India Ltd. 

JSW Steel: The Italian subsidiary of the company has announced securing a Euro 33 million government grant for the Rail Mill Modernisation Project that is being developed at an estimated cost of Euro 143 million, which will be implemented by the company at Piombino. 

JB Chemicals & Pharmaceuticals: The company has announced securing final approval from the USFDA for its Bisoprolol tablets USP, 5 mg, and 10 mg, which is a generic version of Zebeta for hypertension treatment.

The future of investing is here!
Unicorn Signals leverages advanced AI technology to provide you with powerful market predictions and actionable stock scans. Download the app todayand 10x your trading & investing journey!